CHCR: AI 评分 46/100 — AI 分析 (4月 2026)

Advanzeon Solutions, Inc., operating through its subsidiary, focuses on administering and operating the SleepMaster Solutions sleep apnea program. The company filed for Chapter 11 bankruptcy in 2020 and currently trades on the OTC market.

Key Facts: AI Score: 46/100 Sector: Healthcare

公司概况

概要：

Advanzeon Solutions, Inc. operates in the healthcare sector, focusing on sleep apnea program administration through its SleepMaster Solutions. Currently trading on the OTC market after a Chapter 11 filing, the company faces challenges in a competitive medical care facilities landscape.

CHCR是做什么的？

Advanzeon Solutions, Inc., formerly known as Comprehensive Care Corporation, was established in 1969 and rebranded in January 2014. Headquartered in Tampa, Florida, the company operates through its subsidiary, Pharmacy Value Management Solutions, Inc., which administers and manages the SleepMaster Solutions program, a sleep apnea treatment service. Advanzeon's core business revolves around providing solutions for individuals suffering from sleep apnea, a prevalent condition affecting millions. However, on September 7, 2020, Advanzeon Solutions, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, impacting its operational and financial stability. The company's long-term viability hinges on its ability to restructure and regain market confidence while navigating the competitive landscape of the medical care facilities industry.

CHCR的投资论点是什么？

Investing in Advanzeon Solutions, Inc. (CHCR) presents significant risks due to its OTC market listing and recent Chapter 11 bankruptcy filing in 2020. The company's reliance on the SleepMaster Solutions program for revenue makes it vulnerable to market shifts and competition. With a market capitalization of $0.00B and a beta of 1.24, CHCR exhibits high volatility. Potential investors should closely monitor the company's restructuring efforts and ability to regain financial stability. Growth catalysts are uncertain, and the company's future depends on successfully navigating its bankruptcy proceedings and re-establishing a competitive position in the healthcare sector.

CHCR在哪个行业运营？

Advanzeon Solutions, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is characterized by increasing demand for specialized care services, including sleep apnea treatment. However, the competitive landscape is intense, with established players and emerging technologies vying for market share. Advanzeon's position is challenged by its recent bankruptcy filing and the need to restructure its operations. The industry is also subject to regulatory changes and reimbursement pressures, further impacting the company's prospects.

Medical - Care Facilities

Healthcare

CHCR有哪些增长机遇？

Expansion of Sleep Apnea Program: Advanzeon could focus on expanding its SleepMaster Solutions program by targeting new geographic markets and patient demographics. The global sleep apnea devices market is projected to reach $5.2 billion by 2027, offering a substantial growth opportunity. Success depends on effective marketing, strategic partnerships, and demonstrating superior patient outcomes.
Telehealth Integration: Integrating telehealth services into the SleepMaster Solutions program could enhance accessibility and convenience for patients, particularly in remote areas. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing demand for remote healthcare solutions. This integration could improve patient engagement and reduce operational costs.
Strategic Partnerships: Forming strategic alliances with healthcare providers, insurance companies, and sleep clinics could expand Advanzeon's reach and market penetration. Partnerships can provide access to new patient referrals, distribution channels, and reimbursement opportunities. Successful partnerships require alignment of goals, clear communication, and mutual benefit.
Product Diversification: Diversifying beyond sleep apnea treatment into related respiratory care services could broaden Advanzeon's revenue streams and reduce its reliance on a single product line. This could include offering diagnostic services, respiratory therapy, and home healthcare solutions. Diversification requires careful market research, investment in new technologies, and skilled personnel.
Cost Optimization: Implementing cost-saving measures and streamlining operations could improve Advanzeon's financial performance and enhance its competitiveness. This includes optimizing supply chain management, reducing administrative expenses, and improving operational efficiency. Cost optimization is crucial for companies facing financial challenges and can improve profitability and cash flow.

Advanzeon Solutions, Inc. operates the SleepMaster Solutions sleep apnea program.
The company filed for Chapter 11 bankruptcy on September 7, 2020.
CHCR trades on the OTC market, indicating higher risk and lower liquidity.
The company's market capitalization is $0.00B, reflecting its distressed financial state.
The company's beta is 1.24, indicating higher volatility than the market.

CHCR提供哪些产品和服务？

Administers and operates the SleepMaster Solutions sleep apnea program.
Provides solutions for individuals suffering from sleep apnea.
Operates through its subsidiary, Pharmacy Value Management Solutions, Inc.
Offers sleep apnea treatment services.
Focuses on managing sleep apnea programs.
Aims to improve the quality of life for sleep apnea patients.

CHCR如何赚钱？

Generates revenue through the SleepMaster Solutions program.
Provides sleep apnea treatment services to patients.
Partners with healthcare providers and insurance companies.
Focuses on program administration and management.

Individuals suffering from sleep apnea.
Healthcare providers and sleep clinics.
Insurance companies covering sleep apnea treatment.
Patients seeking solutions for sleep-related breathing disorders.

Proprietary SleepMaster Solutions program.
Established relationships with healthcare providers.
Experience in sleep apnea program administration.
Focus on specialized care services.

什么因素可能推动CHCR股价上涨？

Upcoming: Successful restructuring and emergence from Chapter 11 bankruptcy could restore investor confidence.
Ongoing: Expansion of the SleepMaster Solutions program into new markets could drive revenue growth.
Ongoing: Strategic partnerships with healthcare providers could enhance market penetration.

CHCR的主要风险是什么？

Ongoing: Financial instability due to Chapter 11 bankruptcy.
Potential: Intense competition in the medical care facilities industry.
Potential: Regulatory changes and reimbursement pressures.
Ongoing: Limited liquidity and high volatility due to OTC market listing.
Potential: Dependence on a single product line (SleepMaster Solutions).

CHCR的核心优势是什么？

Specialized SleepMaster Solutions program.
Experience in sleep apnea program administration.
Established presence in the healthcare sector.
Focus on a specific medical condition.

CHCR的劣势是什么？

Recent Chapter 11 bankruptcy filing.
OTC market listing indicating higher risk.
Limited market capitalization.
Reliance on a single product line.

CHCR有哪些机遇？

Expansion into new geographic markets.
Integration of telehealth services.
Strategic partnerships with healthcare providers.
Diversification into related respiratory care services.

CHCR面临哪些威胁？

Intense competition in the medical care facilities industry.
Regulatory changes and reimbursement pressures.
Potential for product obsolescence.
Economic downturn affecting patient affordability.

CHCR的竞争对手是谁？

Acorus Therapeutics Inc — Focuses on neurological solutions. — (ACORQ)
CBD of Denver, Inc. — Operates in the cannabis industry. — (CBDHF)
Gold By Gold Mining Inc — Operates in the mining industry. — (GDBYF)
Genasys Inc. — Provides critical communication systems. — (GENN)
Gen Bio Technology Inc — Focuses on biotechnology solutions. — (GNBT)

Key Metrics

MoonshotScore: 46/100

Company Profile

CEO: Clark A. Marcus
Headquarters: Tampa, US
Employees: 2
Founded: 1975

AI Insight

AI analysis pending for CHCR

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Advanzeon Solutions, Inc. do?

Advanzeon Solutions, Inc., through its subsidiary Pharmacy Value Management Solutions, Inc., administers and operates the SleepMaster Solutions program, which provides sleep apnea treatment services. The company focuses on managing sleep apnea programs and offering solutions to individuals suffering from sleep-related breathing disorders. Despite its long history, Advanzeon filed for Chapter 11 bankruptcy in 2020 and currently trades on the OTC market, reflecting its distressed financial condition and challenging business environment.

What do analysts say about CHCR stock?

Given Advanzeon Solutions, Inc.'s OTC listing and recent bankruptcy filing, formal analyst coverage is unlikely. Key valuation metrics are difficult to assess due to the company's financial instability. Growth considerations are highly speculative, contingent on successful restructuring and market recovery. Investors should conduct thorough due diligence and consider the significant risks associated with this stock. There is no consensus or recommendation available from analysts.

What are the main risks for CHCR?

The main risks for Advanzeon Solutions, Inc. include its ongoing Chapter 11 bankruptcy proceedings, which create uncertainty about its future viability. Its OTC market listing indicates higher risk and lower liquidity. The company's reliance on the SleepMaster Solutions program makes it vulnerable to competition and market shifts. Additionally, regulatory changes and reimbursement pressures in the healthcare sector could negatively impact its financial performance. Investors should carefully consider these risks before investing.